Metabolic changes during medical treatment of endometriosis: Nafarelin acetate versus danazol
- 1 June 1989
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 160 (6) , 1454-1461
- https://doi.org/10.1016/0002-9378(89)90870-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Effect of a Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin) on Bone MetabolismJournal of Clinical Endocrinology & Metabolism, 1988
- Pelvic Endometriosis: Etiology and PathologySeminars in Reproductive Medicine, 1988
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.BMJ, 1987
- LHRH ANALOGUES AND BONE LOSSThe Lancet, 1987
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJAMA, 1986
- Lowering Blood Cholesterol to Prevent Heart DiseaseJAMA, 1985
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955